Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

MDAT

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
MDAT
Clinical data
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • In general: uncontrolled
Identifiers
  • 5,6,7,8-tetrahydrobenzo[f][1,3]benzodioxol-6-amine
CAS Number
PubChemCID
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC11H13NO2
Molar mass191.230 g·mol−1
3D model (JSmol)
  • C3Cc1cc2OCOc2cc1CC3N

6,7-Methylenedioxy-2-aminotetralin (MDAT) is adrug developed in the 1990s by a team atPurdue University led byDavid E. Nichols.[1] It appears to act as aserotonin releasing agent based on rodent drug discrimination assays comparing it toMDMA, in which it fully substitutes for, and additionally lacks any kind ofserotonergicneurotoxicity.[1] Hence, MDAT is considered likely to be a non-neurotoxic, putativeentactogen in humans.

See also

[edit]

References

[edit]
  1. ^abNichols DE, Brewster WK, Johnson MP, Oberlender R, Riggs RM (February 1990). "Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA)".Journal of Medicinal Chemistry.33 (2):703–10.doi:10.1021/jm00164a037.PMID 1967651.
Phenylalkyl-
amines

(other than
cathinones)
Cyclizedphenyl-
alkylamines
Cathinones
Tryptamines
Chemical classes
DRAsTooltip Dopamine releasing agents
NRAsTooltip Norepinephrine releasing agents
SRAsTooltip Serotonin releasing agents
Others
Retrieved from "https://en.wikipedia.org/w/index.php?title=MDAT&oldid=1216582179"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp